Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 3075 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

AlphaRx signs R&D agreement with US Army

The resulting joint R&D effort is expected to enable US Army Medical Research Institute of Infectious Diseases (USAMRIID) scientists to test the efficacy of AlphaRx’s ‘nanobiotics’ for the

Disc Motion Technologies names new CEO

Mr Greenberg brings to Disc Motion Technologies an extensive background in the orthopaedic and spine industries as well as executive leadership in various roles. Mr Greenberg’s prior experience

WuXi names new vice president

In his new role as vice president of discovery biology, Mr Wang will oversee the company’s growing portfolio of discovery biology service offerings. Prior to joining WuXi PharmaTech,

Favrille’s lymphoma drug fails end point

Analysis of time to progression (TTP), the primary endpoint in the trial, failed to show a statistically significant improvement in the treatment arm, Specifid plus Leukine following Rituxan,

Yissum introduces new diagnostic device

The disposable device removes amylase from whole saliva (and other body fluids) in a simple and efficient procedure. The device takes advantage of modified potato starch, which is